Chronic News and Research

RSS

Researchers to study interventional endovascular therapy on symptoms and progression of MS

Buffalo medical researchers led by a team from the University at Buffalo Department of Neurosurgery, will embark on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy -- dubbed "liberation treatment" -- on the symptoms and progression of Multiple Sclerosis.

1 Jul 2010

Advancements in total hip replacement procedure make young patients opt for surgery

Traditionally, total hip replacement surgery was performed on the elderly, but these days, advancements in the procedure have patients opting for the surgery much earlier in life.

1 Jul 2010

Constituents of the U.S. healthcare system ready to adopt value-based insurance designs: Study

A new study commissioned by The TriZetto Group, Inc. finds that doctors, health insurers, consumers and other constituents of the U.S. healthcare system say they are ready and willing to adopt value-based insurance designs and related payment programs. Such designs encourage patients and clinicians to make better choices to improve care based on proven best practices, using both better information and financial incentives.

1 Jul 2010

Lawmakers urge swifter launch of home health care demo

"The so-called Independence at Home (IAH) program, included as part of the Democrats' new health reform law, is scheduled to take effect no later than Jan. 1, 2012, but Sen. Ron Wyden (D-Ore.) and Rep. Edward Markey (D-Mass.) warn that waiting that long would threaten the health of one of the country's most vulnerable populations," The Hill reports.

1 Jul 2010

Eisai reports preliminary results from Dacogen for Injection Phase III study in AML

Eisai Inc. announced today preliminary results from a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally occurs in older adults.

1 Jul 2010

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Scientists are reporting a possible explanation for the symptoms of anxiety and depression that occur in some patients taking the popular statin family of anti-cholesterol drugs, and reported by some individuals on low-cholesterol diets. These symptoms could result from long-term, low levels of cholesterol in the brain, the report suggests. It appears in ACS' weekly journal Biochemistry.

1 Jul 2010

Neuralstem announces completion of $10 million registered direct offering

Neuralstem, Inc. (NYSE Amex: CUR) announced that it has completed its previously announced registered direct offering of $10 million of units to institutional investors. The units were priced at $2.80 and consisted of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant. The warrants have an exercise price of $3.25 and a term of three years. Net proceeds from this offering, after deducting placement agent fees and other offering expenses, total approximately $9.2 million. All of the securities were offered pursuant to an effective shelf registration statement.

1 Jul 2010

Vicept completes $16 million Series A financing

Vicept™ Therapeutics Inc., a privately held specialty biopharmaceutical company dedicated to developing the first effective topically applied therapy for erythema (facial redness) of rosacea, announced that it has secured $10 million to complete a total $16 million Series A financing. The Series A was led by Vivo Ventures, Sofinnova Ventures and Fidelity Biosciences.

30 Jun 2010

Calistoga Pharmaceuticals closes $40 million Series C financing

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced it has closed a $40 million Series C financing. The financing was led by Quogue Capital, LLC along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners and new investor Latterell Venture Partners.

30 Jun 2010

Investment report on BioCryst Pharmaceuticals

MicroStockProfit.com announces an investment report featuring BioCryst Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

30 Jun 2010

Transition commences dosing in TT-301 Phase 1 clinical study for rheumatoid arthritis, ICH, TBI

Transition Therapeutics Inc. announced today that the first patient has been dosed with drug candidate TT-301 in a Phase 1 clinical study. TT-301 is a small molecule compound that has demonstrated efficacy in preclinical models of rheumatoid arthritis, intracerebral haemorrhage and traumatic brain injury.

30 Jun 2010

Infection and severe sepsis mortality rates higher in black patients

A greater frequency of severe sepsis among black patients is attributable to higher rates of infection and higher risks of organ dysfunction than what white patients experience, according to a study in the June 23/30 issue of JAMA.

30 Jun 2010

European Congress of Nephrology unveils results of various clinical trials

The 47th ERA-EDTA/DGfN congress in Munich has been the setting for a wide range of new clinical data. The results of the following clinical trials were presented at "Late-Breaking Clinical Trials Sessions."

30 Jun 2010

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was compared with standard glucose control.

30 Jun 2010

Geriatric population soars while NIH devotes modest resources to aging research

With a nudge from the new health care law and pressure from Medicare, hospitals, doctors and nurses are struggling to prepare for explosive growth in the numbers of high-risk elderly patients. More than 40 percent of adult patients in acute care hospital beds are 65 or older. Seventy million Americans will have turned 65 by 2030.

30 Jun 2010

U.S., China open Shanghai Epidemiology Center for chronic, epidemic diseases

Chinese and U.S. health officials opened an epidemiology center in Shanghai Tuesday to train experts to deal with and prevent chronic and epidemic diseases, the Associated Press reports.

30 Jun 2010

New strategies can improve continuity of primary care, shorten patient waiting time

A national shortage of primary care doctors plus a growing population of older adults, many with chronic diseases, is leading in some underserved areas to longer wait times to see a doctor and is reducing patients' chances of seeing their own physician, experts say.

30 Jun 2010

Rise in hospital admissions over last five years

According to a new ‘State of Our Public Hospitals’ report there is a 17 percent hike in the number of people seeking treatment at Australian hospitals in the last five years. This report was released by Health Minister Nicola Roxon on Tuesday.

29 Jun 2010

Arizona Integrated Physicians to implement eClinicalWorks unified EMR/PM system

eClinicalWorks®, a market leader in ambulatory clinical systems, today announced that Arizona Integrated Physicians (AIP), a physician-owned organization, has chosen eClinicalWorks unified electronic medical records (EMR) and practice management (PM) system for its approximately 600 physicians.

29 Jun 2010

Successful growth of mouse embryonic stem cells in rat lungs raises hopes for engineering human transplants

For someone with a severe, incurable lung disorder such as cystic fibrosis or chronic obstructive pulmonary disease, a lung transplant may be the only chance for survival. Unfortunately, it's often not a very good chance. Matching donor lungs are rare, and many would-be recipients die waiting for the transplants that could save their lives.

29 Jun 2010

Chronic News and Research

Researchers to study interventional endovascular therapy on symptoms and progression of MS

Advancements in total hip replacement procedure make young patients opt for surgery

Constituents of the U.S. healthcare system ready to adopt value-based insurance designs: Study

Lawmakers urge swifter launch of home health care demo

Eisai reports preliminary results from Dacogen for Injection Phase III study in AML

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Neuralstem announces completion of $10 million registered direct offering

Vicept completes $16 million Series A financing

Calistoga Pharmaceuticals closes $40 million Series C financing

Investment report on BioCryst Pharmaceuticals

Transition commences dosing in TT-301 Phase 1 clinical study for rheumatoid arthritis, ICH, TBI

Infection and severe sepsis mortality rates higher in black patients

European Congress of Nephrology unveils results of various clinical trials

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

Geriatric population soars while NIH devotes modest resources to aging research

U.S., China open Shanghai Epidemiology Center for chronic, epidemic diseases

New strategies can improve continuity of primary care, shorten patient waiting time

Rise in hospital admissions over last five years

Arizona Integrated Physicians to implement eClinicalWorks unified EMR/PM system

Successful growth of mouse embryonic stem cells in rat lungs raises hopes for engineering human transplants

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News